• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance.

作者信息

Ready Kaylene, Gutierrez-Barrera Angelica M, Amos Christopher, Meric-Bernstam Funda, Lu Karen, Hortobagyi Gabriel, Arun Banu

出版信息

Breast J. 2011 Mar-Apr;17(2):210-2. doi: 10.1111/j.1524-4741.2010.01055.x. Epub 2011 Feb 7.

DOI:10.1111/j.1524-4741.2010.01055.x
PMID:21294809
Abstract
摘要

相似文献

1
Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance.携带意义未明的BRCA1或BRCA2基因变异女性的癌症风险管理决策。
Breast J. 2011 Mar-Apr;17(2):210-2. doi: 10.1111/j.1524-4741.2010.01055.x. Epub 2011 Feb 7.
2
The clinical management of BRCA1 and BRCA2 mutation carriers.BRCA1和BRCA2基因突变携带者的临床管理。
Curr Oncol Rep. 2008 Jan;10(1):47-53. doi: 10.1007/s11912-008-0008-9.
3
Evaluation and management of women with BRCA1/2 mutations.携带BRCA1/2基因突变女性的评估与管理
Oncology (Williston Park). 2005 Oct;19(11):1451-9; discussion 1459-68 1474.
4
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.使用BOADICEA和BRCAPRO模型对高危法裔加拿大家庭进行BRCA1和BRCA2突变预测及外显率估计
Breast Cancer Res. 2006;8(1):R3. doi: 10.1186/bcr1365. Epub 2005 Dec 12.
5
Prognosis of probability of BRCA1 and BRCA2 mutations carriage in women with compromised family history of breast and/or ovarian cancer.乳腺癌和/或卵巢癌家族史不良的女性携带BRCA1和BRCA2基因突变概率的预后情况。
Probl Radiac Med Radiobiol. 2013(18):253-60.
6
BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management.
Semin Oncol. 2011 Oct;38(5):605-11. doi: 10.1053/j.seminoncol.2011.04.009.
7
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.降低风险的输卵管卵巢切除术预防BRCA1和BRCA2相关乳腺癌及妇科癌症：一项多中心前瞻性研究
J Clin Oncol. 2008 Mar 10;26(8):1331-7. doi: 10.1200/JCO.2007.13.9626. Epub 2008 Feb 11.
8
Changes in classification of genetic variants in BRCA1 and BRCA2.BRCA1和BRCA2基因变异分类的变化。
Arch Gynecol Obstet. 2018 Feb;297(2):279-280. doi: 10.1007/s00404-017-4631-2. Epub 2018 Jan 4.
9
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.意大利乳腺癌和/或卵巢癌家族中新型BRCA1和BRCA2种系突变以及突变谱和患病率评估
Breast Cancer Res Treat. 2006 Nov;100(1):83-91. doi: 10.1007/s10549-006-9225-9. Epub 2006 May 9.
10
Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.在捷克共和国，高危先证者或有乳腺癌或卵巢癌先证者的 BRCA 基因和其他候选基因的突变频率。
Mol Biol Rep. 2020 Apr;47(4):2763-2769. doi: 10.1007/s11033-020-05378-7. Epub 2020 Mar 16.

引用本文的文献

1
Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers.蛋白质折叠伴侣可预测 BRCA1 突变携带者的结构-功能关系和癌症风险。
Cell Rep. 2024 Feb 27;43(2):113803. doi: 10.1016/j.celrep.2024.113803. Epub 2024 Feb 17.
2
Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.接受遗传性乳腺癌、卵巢癌及林奇综合征基因检测患者中意义未明变异的患病率
Cancers (Basel). 2023 Dec 8;15(24):5762. doi: 10.3390/cancers15245762.
3
How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?
意义未明的变异（VUS）的重新分类如何影响遗传性乳腺癌风险患者的管理？
BMC Med Genomics. 2022 May 31;15(1):122. doi: 10.1186/s12920-022-01270-4.
4
Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives.接受基因检测的乳腺癌患者中意义未明变异的发生率：区域视角
Front Oncol. 2022 Mar 25;12:673094. doi: 10.3389/fonc.2022.673094. eCollection 2022.
5
Prevalence and Spectrum of Germline and Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.乳腺癌/卵巢癌中生殖系变异及意义未明变异的患病率和谱系：来自基因组的神秘信号
Front Oncol. 2021 Jun 11;11:682445. doi: 10.3389/fonc.2021.682445. eCollection 2021.
6
Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.在韩国遗传性乳腺癌前瞻性研究中分析意义未明的 BRCA1/2 变异体。
Sci Rep. 2021 Apr 19;11(1):8485. doi: 10.1038/s41598-021-87792-w.
7
The influence of BRCA variants of unknown significance on cancer risk management decision-making.BRCA 意义未明变异对癌症风险管理决策的影响。
J Gynecol Oncol. 2019 Jul;30(4):e60. doi: 10.3802/jgo.2019.30.e60. Epub 2019 Feb 27.
8
Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era.回顾精准医学时代BRCA和PALB2相关癌症的特征。
Genet Mol Biol. 2019;42(1 suppl 1):215-231. doi: 10.1590/1678-4685-GMB-2018-0104. Epub 2019 Apr 29.
9
BRCA1/2 Variant Data-Sharing Practices.BRCA1/2 变异数据共享实践。
J Law Med Ethics. 2019 Mar;47(1):88-96. doi: 10.1177/1073110519840487.
10
Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of Variants of Uncertain Significance.在不确定意义变异体临床相关性定义中mRNA剪接谱全面表征的实用性与局限性
Cancers (Basel). 2019 Mar 1;11(3):295. doi: 10.3390/cancers11030295.